Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol plus neoadjuvant chemotherapy for locally advanced or metastatic breast cancer (phase II, single-arm)
ChiCTR2500108957Phase 2Not yet recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propranolol in breast cancer, sponsored by Anhui Provincial Tumor Hospital. Primary endpoints: Pathological complete remission (pCR) rate and Anxiety score. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2500108957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108957.